INSIGHTS ON CLINICAL TRIAL DESIGN
-
Cell And Gene Therapy Field Quiet In Q2
While there weren't any new gene or cell therapy approvals in Q2 2024, the U.S. approved two RNA therapies: Rytelo, an oligonucleotide telomerase inhibitor, and mRESVIA, an mRNA vaccine.
-
Pay-By-Procedure Or Pay-By-Visit: Which Model Fits Your Trial?
Site payment models shape trial cost and execution. Compare visit‑based simplicity vs procedure‑level precision to see when flexibility and savings beat complexity — or when predictability wins.
-
Ways To Avoid Rescue Trials From The Start
What puts a trial in rescue mode? Poor clinical planning, overly complex protocols, missed deadlines, insufficient resources, and noncompliance are a few reasons. Sponsors can avoid a rescue in the first place by addressing these obstacles before they become delays.
-
Patient Trust And Engagement In The Age Of Decentralized Trials
To truly maximize enrollment in decentralized models, sponsors must invest in human connection to build the trust needed to move patients from awareness to active participation.
-
Beyond Help Desk: RTSM Support Ready For Change3/25/2026
This clip explores what sponsors should expect from an RTSM support model built for long‑term study needs, emphasizing capacity, flexibility, and readiness to adapt as trials evolve.
-
How The Right Meetings Make Patient-Centered Trial Design Possible7/30/2025
Including patients in trial design improves recruitment, retention, and site experience. Explore practical ways sponsors can gather early input—without disrupting timelines or adding complexity.
-
4 Core Biomarker-Driven Study Designs In Oncology2/19/2026
Modern oncology demands smarter trial designs. Explore how enrichment, stratification, and basket models transform biomarker data into successful, regulatory-ready clinical programs.
-
Multi-Regional Clinical Trials: The Latest Guidance From FDA3/12/2025
Conducting multi-regional clinical trials (MRCTs) is essential for accelerating oncology drug development and ensuring broader patient access. However, differences across regions can impact findings.
-
DCTs For Older Adults: Mobile Research Trends And Recommendations7/9/2024
Learn how DCTs can be tailored to suit the needs of older adults, potentially transforming geriatric clinical research and addressing the unique challenges faced by this growing population.
CLINICAL TRIAL DESIGN SOLUTIONS
-
Scout delivers patient engagement solutions that keep participants involved in clinical trials while supporting sites, sponsors, and CROs.
With tools that manage payments, travel, and communication, we make it easy for participants to stay connected and confident throughout their trial journey.
-
AutoCruitment's patient recruitment services have assisted with 700+ trials in more than 38 countries. Looking for patients with over 120 different conditions, they have enrolled 14600+ patients and achieved a 97% increase in randomization.
-
With TrialScope Disclose, study sponsors streamline and optimize the entire clinical trial disclosure process from initial registration to final results — mitigating risk, maximizing transparency and ultimately moving healthcare forward.
-
Infectious diseases are a threat to global health and way of life everywhere. Time is of the essence when it comes to developing safe and effective infectious disease vaccines and treatments.
-
Discover how to seamlessly integrate a broad range of leading industry solutions to create an innovative, patient-centered approach that caters to specific diversity and clinical trial requirements.